Hancock Whitney’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Hancock Whitney’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,528	Closed	-$886K	–	742
2021 Q4	$886K	Sell	9,528 -895	-9%	-$59K	0.03%	355
2021 Q3	$621K	Buy	10,423 +3,775	+57%	+$223K	0.02%	414
2021 Q2	$453K	Sell	6,648 -19,133	-74%	-$1.25M	0.01%	578
2021 Q1	$1.79M	Sell	25,781 -1,144	-4%	-$88K	0.06%	302
2020 Q4	$2.07M	Sell	26,925 -783	-3%	-$58.7K	0.07%	258
2020 Q3	$2.07M	Sell	27,708 -1,020	-4%	-$68K	0.08%	212
2020 Q2	$1.81M	Sell	28,728 -6,268	-18%	-$345K	0.07%	249
2020 Q1	$1.47M	Buy	34,996 +5,917	+20%	+$271K	0.06%	299
2019 Q4	$1.32M	Buy	+29,079	New	+$1.37M	0.04%	386

Hancock Whitney's ARNA Position: Q1 2022 in Review

Hancock Whitney sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 9,528 shares — an estimated $886K sold.

Hancock Whitney first reported a position in ARNA in Q4 2019 and held it in 9 quarters. The position peaked at $2.07M in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Hancock Whitney reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Hancock Whitney sold 9,528 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $886K.
Hancock Whitney first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 9 quarters.
Hancock Whitney's Arena Pharmaceuticals Inc position peaked at $2.07M in Q3 2020.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Hancock Whitney's 13F filing for Q1 2022, filed 12 May 2022.